NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18)

Funding Agency:
National Institutes of Health

The goal of this Funding Opportunity Announcement (FOA) is to enable the development of 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at the National Center for Advancing Translational Sciences (NCATS) and extramural scientists.

NCATS intramural scientists will provide expertise for 3-D bioprinting, assay development and drug screening stages of the projects.  Extramural investigators will provide appropriate cell resources, disease expertise and model validation in collaboration with NCATS to perform drug screening of bioprinted materials. The research application will involve 3-D bioprinting in a screening format of patient-derived cells supplied by the extramural investigators, characterization and validation of bioprinted materials by NCATS investigators and extramural collaborators, and screening of appropriate molecular libraries.  


  • Letter of Intent Due Date(s): February 28, 2017
  • Application Due Date(s): April 14, 2017

RFA-TR-17-007 Expiration Date April 15, 2017

Agency Website



Amount Description

Application budgets are limited to $400,000 in direct costs per year and should reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period.  The maximum project period is 2 years.

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science

External Deadline

April 14, 2017